Literature DB >> 23572159

Cancer pain.

Sebastiano Mercadante1.   

Abstract

PURPOSE OF REVIEW: Cancer pain management is in continuous innovation and new data are available that could change the therapeutical approach and guidelines. RECENT
FINDINGS: There are different fields of research that produce new data and interesting findings. The principal data regard the factors influencing the analgesic response, breakthrough cancer pain management, opioid switching, and pharmacogenetics.
SUMMARY: The findings reported in this review provide new ideas to be developed in further studies to confirm or not confirm some suggestive data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572159     DOI: 10.1097/SPC.0b013e3283610433

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  6 in total

Review 1.  Options for Treating Pain in Cancer Patients with Dysphagia.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

2.  Opioid Rotation in Cancer Pain Treatment.

Authors:  Michael Schuster; Oliver Bayer; Florian Heid; Rita Laufenberg-Feldmann
Journal:  Dtsch Arztebl Int       Date:  2018-03-02       Impact factor: 5.594

Review 3.  Cancer Pain Treatment Strategies in Patients with Cancer.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2022-09-21       Impact factor: 11.431

4.  Fentanyl Inhibits Tumorigenesis from Human Breast Stem Cells by Inducing Apoptosis

Authors:  Nadir Kocak; Filiz Ozen; Ibrahim Halil Yildirim; Yagmur Duran
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

5.  Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain.

Authors:  Josep Darbà; Lisette Kaskens; Rainel Sánchez-de la Rosa
Journal:  Clinicoecon Outcomes Res       Date:  2013-12-16

6.  Pain-related mediators underlie incision-induced mechanical nociception in the dorsal root ganglia.

Authors:  Xiuhong Yuan; Xiangyan Liu; Qiuping Tang; Yunlong Deng
Journal:  Neural Regen Res       Date:  2013-12-15       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.